Children's Health Defense The FDA will approve leucovorin, a medication used in cancer treatments to counter the harmful side effects of other drugs, as an autism treatment after it showed promise in some patients, the Trump administration announced Monday — but some scientists caution that more research is needed.
In a statement, the U.S. Food and Drug Administration (FDA) said leucovorin will be approved for autistic people with cerebral folate deficiency (CFD), a neurological condition that affects the transport of folate — an essential vitamin for brain health — into the brain. Leucovorin is a type of folate called folinic acid.
CFD patients have “developmental delays with autistic features,” including seizures, problems with movement and coordination, repetitive behaviors, and difficulties with communication and sensory processing, according to the FDA…
READ FULL ARTICLE HERE… (childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
Be First to Comment